A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous cd34+ cell administration in patients with refractory angina: Design of the renew study

Thomas J. Povsic, Candice Junge, Adel Nada, Richard A. Schatz, Robert A. Harrington, Charles J. Davidson, F. David Fortuin, Dean J. Kereiakes, Farrell O. Mendelsohn, Warren Sherman, Gary L. Schaer, Christopher J. White, Duncan Stewart, Kenneth Story, Douglas W. Losordo, Timothy D. Henry

Research output: Contribution to journal › Article › peer-review

73 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous cd34+ cell administration in patients with refractory angina: Design of the renew study'. Together they form a unique fingerprint.

Medicine & Life Sciences